Results 1 to 10 of about 2,266 (154)

RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases-advantages and limitations. [PDF]

open access: yesFront Neurol
Although it has been more than 200 years since Parkinson’s disease was described, we have not established biomarkers for its definitive diagnosis yet. Moreover, there is a similar case for the entire group of α-synucleinopathies, which are all characterized by the pathological accumulation of aggregated α-synuclein (α-Syn) in the brain and other ...
Koníčková D   +7 more
europepmc   +6 more sources

Salivary α-Synuclein RT-QuIC Correlates with Disease Severity in de novo Parkinson's Disease. [PDF]

open access: yesMov Disord, 2023
Vivacqua G   +9 more
europepmc   +1 more source

Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder. [PDF]

open access: yesNeurology, 2023
Iranzo A   +14 more
europepmc   +1 more source

Identification of α-Synuclein Proaggregator: Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson's Disease. [PDF]

open access: yesACS Med Chem Lett, 2022
Takada F   +9 more
europepmc   +1 more source

When Proteins Go MAD-Misfolded, Amplified, Detected: Advances in α-Synuclein Pathophysiology and RT-QuIC Detection. [PDF]

open access: yesMol Neurobiol
Labajová N   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy